Skip to main page content
U.S. flag

An official website of the United States government

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1996 Sep;134(6):1483-97.
doi: 10.1083/jcb.134.6.1483.

Merosin and laminin in myogenesis; specific requirement for merosin in myotube stability and survival

P H Vachon  1 , F Loechel, H Xu, U M Wewer, E Engvall
Affiliations

Merosin and laminin in myogenesis; specific requirement for merosin in myotube stability and survival

P H Vachon et al. J Cell Biol. 1996 Sep.

Abstract

Laminin (laminin-1; alpha 1-beta 1-gamma 1) is known to promote myoblast proliferation, fusion, and myotube formation. Merosin (laminin-2 and -4; alpha 2-beta 1/beta 2-gamma 1) is the predominant laminin variant in skeletal muscle basement membranes; genetic defects affecting its structure or expression are the causes of some types of congenital muscular dystrophy. However, the precise nature of the functions of merosin in muscle remain unknown. We have developed an in vitro system that exploits human RD and mouse C2C12 myoblastic cell lines and their clonal variants to study the roles of merosin and laminin in myogenesis. In the parental cells, which fuse efficiently to multinucleated myotubes, merosin expression is upregulated as a function of differentiation while laminin expression is downregulated. Cells from fusion-deficient clones do not express either protein, but laminin or merosin added to the culture medium induced their fusion. Clonal variants which fuse, but form unstable myotubes, express laminin but not merosin. Exogenous merosin converted these myotubes to a stable phenotype, while laminin had no effect. Myotube instability was corrected most efficiently by transfection of the merosin-deficient cells with the merosin alpha 2 chain cDNA. Finally, merosin appears to promote myotube stability by preventing apoptosis. Hence, these studies identify novel biological functions for merosin in myoblast fusion and muscle cell survival; furthermore, these explain some of the pathogenic events observed in congenital muscular dystrophy caused by merosin deficiency and provide in vitro models to further investigate the molecular mechanisms of this disease.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. J Neurol Sci. 1993 Oct;119(1):53-64 - PubMed
    1. Exp Cell Res. 1992 Jul;201(1):137-44 - PubMed
    1. Matrix Biol. 1994 Apr;14(3):209-11 - PubMed
    1. Methods Enzymol. 1994;245:85-104 - PubMed
    1. J Cell Biol. 1989 Aug;109(2):799-809 - PubMed

Publication types

MeSH terms